| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/29/2021 | OCAMPO CHRISTINE | PAO; CAO/Urovant Sciences,Inc. | Disposition | Common Shares | 9.8k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | OCAMPO CHRISTINE | PAO; CAO/Urovant Sciences,Inc. | Disposition | | 69k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | OCAMPO CHRISTINE | PAO; CAO/Urovant Sciences,Inc. | Disposition | Stock Option (Right to Buy) | 133.5k | $3.64 | $485.9k | | 03/29/2021 |
| 03/29/2021 | OCAMPO CHRISTINE | PAO; CAO/Urovant Sciences,Inc. | Disposition | Stock Option (Right to Buy) | 3.8k | $13.65 | $51.2k | | 03/29/2021 |
| 03/29/2021 | OCAMPO CHRISTINE | PAO; CAO/Urovant Sciences,Inc. | Disposition | Stock Option (Right to Buy) | 70k | $6.88 | $481.6k | | 03/29/2021 |
| 03/29/2021 | Legault Pierre | Director | Disposition | Common Shares | 12.5k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | Legault Pierre | Director | Disposition | | 9k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | Legault Pierre | Director | Disposition | Stock Option (Right to Buy) | 13.4k | $7.53 | $100.5k | | 03/29/2021 |
| 03/29/2021 | Legault Pierre | Director | Disposition | Stock Option (Right to Buy) | 36.6k | $8.01 | $293.6k | | 03/29/2021 |
| 03/29/2021 | Legault Pierre | Director | Disposition | Stock Option (Right to Buy) | 25k | $8.78 | $219.5k | | 03/29/2021 |
| 03/29/2021 | Legault Pierre | Director | Disposition | Stock Option (Right to Buy) | 15k | $9.38 | $140.7k | | 03/29/2021 |
| 03/29/2021 | POTTER MYRTLE S | Director | Disposition | Common Shares | 12.5k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | POTTER MYRTLE S | Director | Disposition | | 9k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | POTTER MYRTLE S | Director | Disposition | Stock Option (Right to Buy) | 50k | $8.01 | $400.5k | | 03/29/2021 |
| 03/29/2021 | POTTER MYRTLE S | Director | Disposition | Stock Option (Right to Buy) | 25k | $8.78 | $219.5k | | 03/29/2021 |
| 03/29/2021 | POTTER MYRTLE S | Director | Disposition | Stock Option (Right to Buy) | 15k | $9.38 | $140.7k | | 03/29/2021 |
| 03/29/2021 | BANSAL AJAY | See Remarks | Disposition | Common Shares | 24.9k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | BANSAL AJAY | See Remarks | Disposition | | 115.2k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | BANSAL AJAY | See Remarks | Disposition | Stock Option (Right to Buy) | 140k | $9.66 | $1.4M | | 03/29/2021 |
| 03/29/2021 | Hindman James M. | Director | Disposition | | 9k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | Hindman James M. | Director | Disposition | Stock Option (Right to Buy) | 61k | $10.53 | $642.3k | | 03/29/2021 |
| 03/29/2021 | Hindman James M. | Director | Disposition | Stock Option (Right to Buy) | 15k | $9.38 | $140.7k | | 03/29/2021 |
| 03/29/2021 | Robinson James A. Jr. | PEO;CEO/Urovant Sciences, Inc. | Disposition | Common Shares | 8.4k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | Robinson James A. Jr. | PEO;CEO/Urovant Sciences, Inc. | Disposition | Stock Option (Right to Buy) | 50k | $12.41 | $620.5k | | 03/29/2021 |
| 03/29/2021 | Robinson James A. Jr. | PEO;CEO/Urovant Sciences, Inc. | Disposition | Stock Option (Right to Buy) | 25k | $8.78 | $219.5k | | 03/29/2021 |
| 03/29/2021 | Robinson James A. Jr. | PEO;CEO/Urovant Sciences, Inc. | Disposition | Stock Appreciation Right (Right to Buy) | 845.7k | $9.16 | $7.7M | | 03/29/2021 |
| 03/29/2021 | Kurstjens Sef | Director | Disposition | Common Shares | 12.5k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | Kurstjens Sef | Director | Disposition | | 9k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | Kurstjens Sef | Director | Disposition | Stock Option (Right to Buy) | 13.4k | $7.53 | $100.5k | | 03/29/2021 |
| 03/29/2021 | Kurstjens Sef | Director | Disposition | Stock Option (Right to Buy) | 36.6k | $8.01 | $293.6k | | 03/29/2021 |
| 03/29/2021 | Kurstjens Sef | Director | Disposition | Stock Option (Right to Buy) | 25k | $8.78 | $219.5k | | 03/29/2021 |
| 03/29/2021 | Kurstjens Sef | Director | Disposition | Stock Option (Right to Buy) | 15k | $9.38 | $140.7k | | 03/29/2021 |
| 03/29/2021 | Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | Disposition | Stock Option (Right to Buy) | 146.8k | $7.53 | $1.1M | | 03/29/2021 |
| 03/29/2021 | Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | Disposition | Stock Option (Right to Buy) | 1000 | $13.65 | $13.6k | | 03/29/2021 |
| 03/29/2021 | Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | Disposition | Stock Option (Right to Buy) | 100k | $6.88 | $688k | | 03/29/2021 |
|